---
$id: https://graph.org.ai/products/commodity/51111859
$type: Product
source: UNSPSC
code: "51111859"
title: "Mecasermin"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mecasermin

**UNSPSC Code**: 51111859
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic insulin-like growth factor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7GR9I2683O. European Medicines Agency schedules Mecasermin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08672MIG. Mecasermin generally arises in the molecular formula C331H512N94O101S7. The term MECASERMIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, no, 3 1992, list 32.) MECASERMIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule Mecasermin under HS 29371900 and SITC 54154. SMILES:. As of Q4 2014, MECASERMIN remains the US FDA Preferred Term for this commodity. . Mecasermin bears US NLM identifiers UMLS ID C0904505 and NCI Concept Code C2262.

